基于深度学习的人类表皮生长因子受体2在胃癌中表达的无创评估:一项基于计算机断层扫描的多中心研究
这项回顾性多中心研究纳入三家医院1059例胃癌患者,利用静脉期CT影像组学特征构建8种模型预测HER2表达,其中RFE联合Lasso正则化逻辑回归模型表现最佳,训练集AUC为0.7874(95%CI 0.7346-0.8402),外部测试集AUC为0.8033(95%CI 0.7288-0.8788),决策曲线分析显示该模型净获益更大。
要点
- 静脉期CT影像组学联合RFE与Lasso正则化逻辑回归模型预测胃癌HER2表达,测试集AUC为0.8033。
- 训练集HER2阳性比例为8.60%(52/658),测试集为5.60%(19/320)。
- 该模型在决策曲线分析中较其他模型提供更大的净获益。
核心结论
- 基于CT的HER2预测模型在预测胃癌患者HER2表达方面表现出良好性能。
研究设计与样本
- 回顾性多中心研究,纳入三家医院(A、B、C)共1059例患者,A院和B院患者组成训练集(720例),C院患者为外部测试集(339例);提取静脉期CT影像组学特征,经Z-score归一化和主成分分析简化,采用递归特征消除、方差分析、Relief和Kruskal-Wallis检验进行特征选择,以Lasso正则化逻辑回归和支持向量机建模,通过AUC和决策曲线分析评估。
诊断标准与关键数值
- 训练集HER2阳性比例为8.60%(52/658),测试集为5.60%(19/320);RFE联合Lasso正则化逻辑回归模型训练集AUC为0.7874(95%CI 0.7346-0.8402),测试集AUC为0.8033(95%CI 0.7288-0.8788)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The expression of human epidermal growth factor receptor 2 (HER2) in gastric cancer is closely associated with its treatment outcomes and prognosis. This study aims to develop and validate a HER2 prediction model based on computed tomography (CT). Additionally, the study evaluates the robustness of the proposed model.
MATERIALS AND METHODS: This retrospective study included 1059 patients from three hospitals (A, B, and C), where patients from hospitals A and B formed the training set (720 cases), and patients from hospital C served as the external test set (339 cases). Venous-phase CT radiomic features were extracted, normalized using the Z-score method, and simplified via principal component analysis. Feature selection was performed using recursive feature elimination (RFE), analysis of variance, Relief, and the Kruskal-Wallis (KW) test, followed by modeling using Lasso-regularized logistic regression and Support Vector Machine (SVM) methods. The models were evaluated and validated using the area under the curve (AUC) and decision curve analysis to determine the best-performing model.
RESULTS: The positive proportions of HER2 expression were 8.60% (52/658) in the training set and 5.60% (19/320) in the test set. Eight distinct models were developed to predict HER2 expression. Among these, the model utilizing RFE and Lasso-regularized logistic regression (LR-Lasso) exhibited the highest predictive performance, with AUC values of 0.7874 (95% CI: 0.7346-0.8402) in the training set and 0.8033 (95% CI: 0.7288-0.8788) in the test set. Compared to other models, this model provided a greater net benefit on the decision curve analysis. These results suggest that the proposed model can be effectively applied to predict HER2 expression in patients.
CONCLUSION: The HER2 prediction model demonstrated promising performance in predicting HER2 expression in gastric cancer patients.
引用
- Wu ZH, Ren XR, Meng YQ, et al. Non-invasive Assessment of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Cancer Based on Deep Learning: A Computed Tomography-based Multicenter Study. Acad Radiol. 2025. PMID: 39870563. doi:10.1016/j.acra.2024.12.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。